Subscribe to our press releases
ChromoGenics presents at Redeye Technology Day 2021 on Wednesday, December 1st
ChromoGenics will be participating in Redeye Technology Day on Wednesday, December 1st. Listen to a company presentation followed by an QA led by Redeye’s analysts. The event is a digital event.
December 1st 13:30 – 13:50 ChromoGenics participates in Redeye’s event Redeye Technology Day. CEO Fredrik Fränding will present the company and then answer questions asked by Redeye’s analysts.
We invite stakeholders to listen to the presentation live online via Redeyes hemsida. The event is open for everyone to attend and only requires free registration on Redeye’s platform, you register in the link for the event. It will also be possible to listen to the presentation afterwards via ChromoGenics’ channels.
When: December 1st, 13:30 – 13:50
Where: Redeye
Contact:
Fredrik Fränding, CEO
Tel: +46(0)72 249 24 62
Lars Ericsson, CFO & Head of Communications
Tel: +46 (0)18 430 0430
E-mail: info@chromogenics.com
ChromoGenics
About ChromoGenics
Chromogenics is a proptech company that produces dynamic glass for real estate. The company’s product ConverLight® Dynamic, controls indoor comfort with high daylight transmission, great view and solar heat blocking and thereby reduces cost of cooling. ConverLight® Dynamic is based on a patented solution where electrochromic coatings are laminated in plastic film and then laminated between glass. The plastic film is easy to transport, so long shipments of bulky glass can be avoided. ChromoGenics also offers static glass, ConverLight® Static, and the ConverLight® Energy facade glass solution. ChromoGenics’ stock was listed on Nasdaq First North Growth Market in 2017 and has supplied glass technology to several major real estate companies.
ChromoGenics originates from world-leading research at Ångströmlaboratoriet at Uppsala University. The company’s production facility in Uppsala has been partially financed with conditional loans from Energimyndigheten (Energy Authority) in Sweden. ChromoGenics’ share (CHRO) is listed on Nasdaq First North Growth Market with Erik Penser Bank as Certified Adviser: certifiedadviser@penser.se, 08-463 83 00.
Co-financed by